These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6635442)

  • 21. Rifampin and cloxacillin in the reduction of Staphylococcus aureus colonization.
    Finley RS; Schimpff SC; Fortner CL; Wiernik PH
    Clin Pharm; 1982; 1(4):370-2. PubMed ID: 7185534
    [No Abstract]   [Full Text] [Related]  

  • 22. Enhancement of antistaphylococcal activity of nafcillin and oxacillin by sisomicin and netilmicin.
    Watanakunakorn C; Glotzbecker C
    Antimicrob Agents Chemother; 1977 Sep; 12(3):346-8. PubMed ID: 907328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of antibiotics, alone and in combination, on Panton-Valentine leukocidin production by a Staphylococcus aureus reference strain.
    Dumitrescu O; Badiou C; Bes M; Reverdy ME; Vandenesch F; Etienne J; Lina G
    Clin Microbiol Infect; 2008 Apr; 14(4):384-8. PubMed ID: 18261123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of clindamycin in combination with rifampicin on clindamycin-susceptible and clindamycin-resistant Staphylococcus aureus.
    Watanakunakorn C
    J Antimicrob Chemother; 1985 Sep; 16(3):335-9. PubMed ID: 4055542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New erythromycin derivatives enhance β-lactam antibiotics against methicillin-resistant Staphylococcus aureus.
    Li Z; He M; Dong X; Lin H; Ge H; Shen S; Li J; Ye RD; Chen D
    Lett Appl Microbiol; 2015 Apr; 60(4):352-8. PubMed ID: 25588530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro combinatory antimicrobial effect of plumbagin with oxacillin and tetracycline against Staphylococcus aureus.
    Rondevaldova J; Novy P; Kokoska L
    Phytother Res; 2015 Jan; 29(1):144-7. PubMed ID: 25266704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergistic antibacterial effects of herbal extracts and antibiotics on methicillin-resistant Staphylococcus aureus: A computational and experimental study.
    Kuok CF; Hoi SO; Hoi CF; Chan CH; Fong IH; Ngok CK; Meng LR; Fong P
    Exp Biol Med (Maywood); 2017 Apr; 242(7):731-743. PubMed ID: 28118725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic effects of vancomycin and β-lactams against vancomycin highly resistant Staphylococcus aureus.
    Tabuchi F; Matsumoto Y; Ishii M; Tatsuno K; Okazaki M; Sato T; Moriya K; Sekimizu K
    J Antibiot (Tokyo); 2017 Jun; 70(6):771-774. PubMed ID: 28196977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activities of the combination of quinupristin-dalfopristin with rifampin in vitro and in experimental endocarditis due to Staphylococcus aureus strains with various phenotypes of resistance to macrolide-lincosamide-streptogramin antibiotics.
    Zarrouk V; Bozdogan B; Leclercq R; Garry L; Feger C; Carbon C; Fantin B
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1244-8. PubMed ID: 11257041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Drug-resistance of staphylococcus aureus and detection of mecA gene in all strains isolated from children in Hangzhou].
    Hua CZ; Li JP; Yu HM; Li S; Ye H; Shang SQ
    Zhonghua Er Ke Za Zhi; 2006 May; 44(5):360-3. PubMed ID: 16780714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergism between amikacin and cefazolin against Staphylococcus aureus: a comparative study of oxacillin-sensitive and oxacillin-resistant strains.
    Levy J; Klastersky J
    J Antimicrob Chemother; 1979 Jul; 5(4):365-73. PubMed ID: 489490
    [No Abstract]   [Full Text] [Related]  

  • 32. In vitro antagonistic inhibitory effects of palm seed crude oils and their main constituent, lauric acid, with oxacillin in Staphylococcus aureus.
    Lalouckova K; Skrivanova E; Rondevaldova J; Frankova A; Soukup J; Kokoska L
    Sci Rep; 2021 Jan; 11(1):177. PubMed ID: 33420288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novobiocin and rifampicin in combination against methicillin-resistant Staphylococcus aureus: an in-vitro comparison with vancomycin plus rifampicin.
    Walsh TJ; Auger F; Tatem BA; Hansen SL; Standiford HC
    J Antimicrob Chemother; 1986 Jan; 17(1):75-82. PubMed ID: 3633267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activity of daptomycin alone and in combination with rifampin and gentamicin against Staphylococcus aureus assessed by time-kill methodology.
    Credito K; Lin G; Appelbaum PC
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1504-7. PubMed ID: 17220402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination of anti-tuberculosis drugs with vitamin C or NAC against different Staphylococcus aureus and Mycobacterium tuberculosis strains.
    Khameneh B; Fazly Bazzaz BS; Amani A; Rostami J; Vahdati-Mashhadian N
    Microb Pathog; 2016 Apr; 93():83-7. PubMed ID: 26602814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenotypic and genotypic characterisation of multiple antibiotic-resistant Staphylococcus aureus exposed to subinhibitory levels of oxacillin and levofloxacin.
    Jo A; Ahn J
    BMC Microbiol; 2016 Jul; 16(1):170. PubMed ID: 27473500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro studies simultaneously examining effect of oxacillin on uptake of radiolabeled streptomycin and on associated bacterial lethality in Staphylococcus aureus.
    Zenilman JM; Miller MH; Mandel LJ
    Antimicrob Agents Chemother; 1986 Dec; 30(6):877-82. PubMed ID: 3643772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro activity of coumermycin alone or in combination against Staphylococcus aureus and Staphylococcus epidermidis.
    Van der Auwera P; Klastersky J
    Drugs Exp Clin Res; 1986; 12(4):307-11. PubMed ID: 3013562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rifampin in experimental endocarditis due to Staphylococcus aureus in rabbits.
    Zak O; Scheld WM; Sande MA
    Rev Infect Dis; 1983; 5 Suppl 3():S481-90. PubMed ID: 6635437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of oxacillin-susceptible mecA-positive Staphylococcus aureus: a new type of MRSA.
    Hososaka Y; Hanaki H; Endo H; Suzuki Y; Nagasawa Z; Otsuka Y; Nakae T; Sunakawa K
    J Infect Chemother; 2007 Apr; 13(2):79-86. PubMed ID: 17458674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.